Varicella-zoster virus was serially propagated in a chemically transformed and cloned line of embryo cells (designated "104 Cl") derived from the inbred strain 2 guinea pig. When strain 2 guinea pigs were immunized with varicella-zoster virus subcultivated in the syngeneic cell line, they produced high-titer virusspecific antiserum which lacked antibody against cellular determinants. This immunization procedure offers both practical and theoretical advantages over prior methods which involved inoculation of outbred laboratory animals with varicella-zoster virus grown in allogeneic or xenogeneic cell cultures.
Varicella-zoster virus was serially propagated in a chemically transformed and cloned line of embryo cells (designated "104 Cl") derived from the inbred strain 2 guinea pig. When strain 2 guinea pigs were immunized with varicella-zoster virus subcultivated in the syngeneic cell line, they produced high-titer virusspecific antiserum which lacked antibody against cellular determinants. This immunization procedure offers both practical and theoretical advantages over prior methods which involved inoculation of outbred laboratory animals with varicella-zoster virus grown in allogeneic or xenogeneic cell cultures.
Production of high-titer antiserum to varicella-zoster virus (VZV) continues to be a difficult problem. Since VZV grown by conventional methods in cultured human cells remains cell associated, laboratory animals (guinea pigs and rabbits) immunized with infected cell extracts develop antibodies not only to the virus-specific antigens but also to various human cell determinants (7, 9) . The latter antibodies often interfere with the usefulness of the antiserum and therefore must be removed by exhaustive adsorptions with uninfected cells. An alternative approach involves VZV propagation in a sensitive cell substrate derived from the same species which is to be immunized: both outbred guinea pigs (7) and outbred monkeys (8, 12) The initial four sera also were screened for VZVspecific neutralizing activity by the semimicromethod (6) and were found to contain neutralizing antibody levels equal to or within a twofold dilution of the FAMA titer; a high concordance between results of these two serological assays has also been observed with human sera also (6) . Three assays were employed to test for antibody to nonviral cellular antigens: indirect immunofluorescence on both living and fixed uninfected cells (12, 13) and immune precipitation (4) . No antibodies against human cell surface, cytoplasmic, or nuclear antigens were detected by immunofluorescence at a 1:4 serum dilution. These negative data are in contradistinction to findings in VZV immune sera obtained from guinea pigs immunized with VZV propagated in human cells (7) . The results of immune precipitation are presented in Fig. 2 . Antibodies to the major VZV glycoprotein antigens were present in all four of the initial sera (4, 7), whereas none of the antisera reacted with additional uninfected cell glycoproteins (4) Glycoproteins precipitated by the varicellaimmune guinea pig sera. Detergent-solubilized extracts of VZV-infected cultures labeled with tritiated fucose were mixed with samples of pre-and postimmune sera obtained from each of the four immunized strain 2 guinea pigs. The preimmune sera precipitated insufficient radioactivity (<0. 7%0) for further analysis. In contrast, 14 to 18% of the radioactivity in the antigen sample was removed by the postimmune sera; this precipitating capacity was comparable to that observed in VZV immune sera obtained from hyperimmunized outbred rabbits and guinea pigs (7) . When the latter immune precipitates were analyzed by electrophoresis in a sodium dodecyl sulfate-8% polyacrylamide slab gel as previously described (4), the fluorogram demonstrated three major glycopeptides (+-) with estimated molecular weights of 118,000, 98,000, and 62,000 daltons, uppermost to lowermost, respectively. not shown).
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